Collins Stewart initiates coverage on Amedisys (NASDAQ: AMED) with a Neutral. PT $38.

Collins analyst says, "As the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE